• Barclays lowered its price target for Welltower to $246.00, still indicating potential upside from its current trading price.
• Welltower offers a 1.5% dividend yield, having increased its payout for two consecutive years, though its dividend payout ratio exceeds earnings.
• The aging population and limited senior housing construction could support future demand and occupancy for Welltower's healthcare properties.

Welltower (NYSE: WELL) owns senior housing and other healthcare properties. Barclays lowers its price target for the stock to $246.00 from $259.00. At the quoted share price of $230.29, the new target is about 6.8% higher. A price target is an analyst’s estimate, not a guaranteed future price.

Welltower trades up $4.82, or 2.14%, at $230.29. Its trading-day range is $224.72 to $230.30, while its 52-week range is $166.88 to $255.20. The company has a market capitalization of about $165.94 billion, and trading volume stands at 1.72 million shares.

Income is another consideration for investors. As highlighted by DefenseWorld, Welltower pays an annual dividend of $3.40 per share, a 1.5% yield, and has raised that payment for two consecutive years. The comparison lists National Health Investors (NYSE: NHI) at a higher 1.9% yield on an annual dividend of $0.30 per share.

DefenseWorld also puts Welltower’s dividend payout at 156% of earnings. That means the dividend is larger than reported earnings, though earnings alone do not show all the cash available to pay it. As highlighted by 24/7 Wall Street, an aging population and slower senior housing construction could support demand and occupancy; its supplied excerpts give no figures or conclusions specific to Welltower.